German Billionaire Dietmar Hopp Backs CureVac Further
This article was originally published in The Pink Sheet Daily
Billionaire Dietmar Hopp’s latest CureVac injection – €80 million ($105 million) – is the biggest private financing ever given to a German biotech and brings the total that his venture capital firm, dievini Hopp BioTech holding GmbH & Co, has injected into CureVac to €145 million ($191 million).
You may also be interested in...
The US FDA has slapped a partial clinical hold on Ipsen’s palovarotene clinical trials in rare bone disorders in children less than 14 years old, due to bone growth concerns.
ImCheck’s $53m series B financing will be used to develop antibodies that activate gamma delta T-cells for use against cancer and autoimmune diseases, its CEO tells Scrip.
Novartis’s AI head tells Scrip an open-ended collaboration with Amazon Web Services will ‘transform’ the Swiss major’s global manufacturing operations and distribution centers.